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Previewsafter their initial RIP1-dependent
activation.
This study establishes a paradigm for
a temporally coordinated negative regula-
tory mechanism in the innate immune
system. It demonstrates a selective
cleavage of an activated signaling mole-
cule by the multifunctional caspase-8
enzyme. Importantly, RIP1 or its family
members RIP2 and RIP3 are involved in
not merely the RIG-I or TNFR1 systems.
These molecules play broad roles in
inflammation and regulate multiple sig-
naling cascades including the TLR3,
NOD1, and NOD2 pathways (Meylan and
Tschopp, 2005). Thus, it will be very
important to investigate whether proteo-
lytic cleavage of activated and ubiquiti-
nated RIP family members by caspase-8
or other proteases could be a general
mechanism for restricting innate immu-
nity. Previous studies with conditional
caspase-8-deficient mice have already
reported active functions for caspase-8in preventing rampant inflammation
in vivo (BenMoshe et al., 2007; Kovalenko
et al., 2009). Specific deletion of caspase-
8 in keratinocytes resulted in an excessive
activation of TBK1 and IRF3 (Kovalenko
et al., 2009), which is consistent with
the data presented here. In the future it
will be very interesting to determine
whether the anti-inflammatory functions
of caspase-8 are restricted to RIP1
cleavage and the interferon regulatory
system or whether additional molecules
and other proinflammatory pathways are
also directly affected. Finally, multiple
human chronic diseases like lupus
erythematosus, rheumatoid arthritis, and
inflammatory bowel disease are caused
by deregulated activities of proinflamma-
tory cascades. Future translational
studies are therefore needed to investi-
gate whether defective caspase-8 regula-
tion and subsequent failures to restrict
innate immunity might contribute to
human inflammatory disease.Immunity 3REFERENCES
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Viperin is an interferon-stimulated gene that exerts antiviral effects. In this issue of Immunity, Saitoh et al.
(2011) uncovered an unexpected function of Viperin and lipid bodies in interferon induction by Toll-like
receptors, specifically in plasmacytoid dendritic cells.Interferons (IFNs) andcytokinesare impor-
tant mediators of immune defense against
infections. An effective IFN response
involves two phases: an early phase of
IFNproduction triggeredbypattern recog-
nition receptors (PRRs) that detect patho-
gens and a late phase of IFN signaling
mediated by the type I IFN receptor
(IFNR), which activates the JAK-STAT
signaling pathway to induce hundreds of
interferon stimulated genes (ISGs). ISGs
collectively suppress viral infection, repli-
cation,andassembly,but themechanisms
underlying the antiviral functions of mostISGs remain largely unknown. In this issue
of Immunity, Saitoh et al. (2011) reveal
a surprising role of an ISG, Viperin (virus
inhibitory protein, endoplasmic reticulum-
associated, IFN-inducible), in the first
phase of IFN production mediated by
Toll-like receptor 7 (TLR7) and TLR9 in
plasmacytoid dendritic cells (pDCs).
Importantly, through investigating the
mechanism of IFN regulation by Viperin,
the authors uncover an interesting
connection between lipid storage organ-
ellescalled lipidbodies (alsoknownas lipid
droplets) and antiviral immune defense.Most mammalian cells have the ability
to secrete and respond to IFNs. However,
pDCs are specialized to produce copious
amounts of IFNa, in part through constitu-
tive expression of endosomal TLRs (TLR7
and TLR9) and IRF7, a master transcrip-
tion factor for IFN-a. In addition, TLR
ligands (e.g, CpG DNA) capable of trig-
gering IFN production in pDCs are re-
tained in specialized endosomal vesicles,
and TLRs on the cytosolic surface of these
vesicles recruit signaling proteins
including MyD88, TRAF6, TRAF3, IRAK4,
and IRAK1 (Honda et al., 2005) (Figure 1).4, March 25, 2011 ª2011 Elsevier Inc. 285
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Figure 1. Type-I Interferon Induction by Endosomal TLRs in Plasmacytoid Dendritic Cells
Detection of DNA and RNA in the lumen of endosomes by TLR9 and TLR7, respectively, triggers signal
transduction cascades leading to the production of type I interferons (IFNs) and inflammatory cytokines.
Distinct endosomes are formed during the process of endosome maturation, which accompanies the
process of TLR activation (e.g., TLR9 is activated by proteolytic processing in acidified endosomes),
and the recruitment of signaling proteins including MyD88, IRAK4, IRAK1, TRAF6, and TRAF3. Recruit-
ment of these proteins to distinct endosomes leads to the activation of NF-kB and IRF7, which in turn
govern the production of inflammatory cytokines and IFN, respectively. Secreted IFN binds to IFN receptor
and activates the JAK-STAT pathway to induce many IFN-stimulated genes (ISGs). One of these ISGs is
Viperin, which is localized on the cytosolic surface of lipid bodies. Viperin assembles a signaling complex
on lipid bodies, greatly facilitating IRF7 activation, thereby contributing to high levels of IFNa production in
pDCs.
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PreviewsA signal transduction cascade through
these proteins leads to the recruitment
and activation of IRF7, which then enters
the nucleus to induce IFN-a. Recent
studies identified AP-3 (adaptor protein 3)
as a key protein required for TLR9 traf-
ficking to specialized vesicles called lyso-
some related organelles (LROs) (Blasius
et al., 2010; Sasai et al., 2010). LROs
recruit TRAF3 and IRF7, thereby triggering
IFN-a production. Loss of AP-3 blocks
TLR9 trafficking to LROs such that286 Immunity 34, March 25, 2011 ª2011 ElseTLR9 is retained in another endosomal
compartment capable of inducing proin-
flammatory cytokines, but not IFN-a,
through activation of NF-kB. Thus, TLRs
in distinct intracellular compartments,
termed NF-kB endosomes and IRF7
endosomes (or LROs), trigger production
of inflammatory cytokines and IFNs,
respectively.
The study of Viperin by Saitoh et al.
(2011) adds another layer of regulation of
IFN induction by endosomal TLRs. Viperinvier Inc.is strongly induced by IFNs, as well as by
viral and bacterial infection (Fitzgerald,
2011). The induction of Viperin by viruses
and bacteria is mediated by distinct
PRRs, including TLRs, and requires the
transcription factors IRF3 and IRF7. To
study the role of Viperin in vivo, Saitoh
et al. generated Viperin-deficient mice
and found that Viperin deficiency
impaired TLR7- and TLR9-mediated type
I IFN production in pDCs, but not in other
cell types, including conventional DCs,
macrophages, and fibroblasts. The induc-
tion of IFN by other PRRs, such as TLR4
and RLR (RIG-I like receptors), was not
affected by the loss of Viperin. Viperin
was also dispensable for induction of
inflammatory cytokines, including IL-12,
TNF-a, and IL-1b, in all cell types exam-
ined, including pDCs. Thus, Viperin is
specifically required for IFN induction by
TLR7 and TLR9 in pDCs. Mechanistically,
the authors found that Viperin associates
with TRAF6 and IRAK1 and that Viperin
is required for lysine-63 (K63) polyubiqui-
tination of IRAK1, which is known to
mediate the activation of NF-kB and
IRF7. The kinase IKKa is required for IFN
induction through phosphorylation of
IRF7. However, phosphorylation of IKKa
is normal in the absence of Viperin, sug-
gesting that IKKa phosphorylation is
insufficient to activate IRF7. This result
also implies that Viperin and K63 polyubi-
quitination of IRAK1 are not required for
IKKa activation, but may facilitate IRF7
activation through a mechanism that
remains to be elucidated.
Interestingly, the N terminus of Viperin
contains an amphipathic alpha helix that
targets the protein to the cytoplasmic
face of ER-derived lipid bodies (Hinson
and Cresswell, 2009). The localization of
Viperin on the lipid bodies may be impor-
tant for its antiviral effect, given that some
viruses such as hepatitis C virus replicate
in the lipid bodies (Miyanari et al., 2007).
Saitoh et al. (2011) discovered another
important function of lipid bodies. They
found that TRAF6 and IRAK1, and to
a lesser extent, MyD88, are recruited to
lipid bodies in a Viperin-dependent
manner upon TLR9 stimulation. Viperin
without its N-terminal membrane associa-
tion domain is still able to associate with
TRAF6 and IRAK1, but cannot rescue
IFN induction in Viperin-deficient pDCs.
A chemical inhibitor (U18666A) that
disrupts lipid body formation also
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Previewsprevents the induction of IFN, but not
IL-12, by a TLR9 ligand in pDCs. These
results strongly suggest that the localiza-
tion of Viperin on the surface of lipid
bodies is important for IFN induction.
Immunocytochemistry studies detect
IRF7, but not TLR9, on Viperin-positive
lipid bodies. Thus, lipid bodies may func-
tion at a step downstream of LROs, which
contain TLR9, and the role of Viperin and
lipid bodies may be serving as a plat-
form to assemble a signaling complex
including MyD88, TRAF6, IRAK1, and
IRF7 (Figure 1). Future studies should
determine whether and how the formation
of this complex on the lipid bodies
facilitates IRF7 phosphorylation and/or
nuclear translocation.
The finding that Viperin and its localiza-
tion in lipid bodies are important for IFN
induction provides a mechanism for posi-
tive feedback control, given that Viperin
expression is highly induced by IFNs. If
Viperin is essential for IFN induction,
pDCs must express certain amounts of
Viperin even in the absence of IFN.
Viperin may also be induced through
IFN-independent mechanisms, and the
regulation of Viperin by IFN-dependent
and independent pathways allows for
crosstalk between pDCs and other cells.
In addition to Viperin, several other
proteins that regulate IFN production are
themselves induced by IFN. Examples
include IRF7 and the viral RNA sensors
RIG-I and MDA5. Through positive
feedback loops, these proteins induce
and amplify IFNs, which is important for
a rigorous antiviral response.
It is now clear that pDCs have the
unique ability to engage proteins such asAP-3 and Viperin to assemble signaling
complexes on specialized endosomes
and lipid bodies to activate IRF7, which
then induces large amounts of IFN-a.
However, AP-3 and Viperin expression is
not restricted to pDCs, thereby raising
the question of what makes pDCs
uniquely capable of forming membrane
compartments optimized for IFNa
production.
The discovery of the role of lipid bodies
in IFN production reinforces the recurring
theme that cell signaling, like real estate,
is all about location, location, location.
Multiple signaling pathways can lead to
the production of IFNs, and, remarkably,
all known pathways signal from distinct
intracellular membrane compartments.
In addition to intracellular TLRs, which
detect DNA and RNA in the lumen of
endosomes, other PRRs can detect cyto-
solic nucleic acids and activate signaling
cascades leading to the production of
IFNs (Rehwinkel and Reis e Sousa,
2010). RIG-I-like receptors bind to viral
RNA in the cytosol and transduce the
signal to the adaptor protein MAVS (also
known as IPS-1, CARDIF, or VISA), which
contains a C-terminal transmembrane
domain that anchors the protein to the
mitochondrial outer membrane. The mito-
chondrial localization ofMAVS is essential
for IFN induction (Seth et al., 2005). Cyto-
solic DNA can also induce IFN through
one ormore DNA sensors and the adaptor
protein STING (also known as MITA or
MPYS). STING contains multiple trans-
membrane domains that target the
protein to the ER membrane (Ishikawa
and Barber, 2008). In several cases, it
has been demonstrated that mislocaliza-Immunity 3tion of the adaptor proteins to different
membrane compartments abrogates their
ability to induce IFNs. Thus, signals
emanating from the surface of specific
intracellular organelles are endowed
with the special ability to induce IFNs.
An exciting avenue of future research
is to delineate the signals and sig-
naling complexes on these intracellular
membranes, including the fascinating
lipid bodies.REFERENCES
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